ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
07 mars 2022 16h48 HE
|
The Rosen Law Firm PA
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021...
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
01 mars 2022 12h00 HE
|
Law Offices of Howard G. Smith
BENSALEM, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
26 févr. 2022 09h21 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
22 févr. 2022 14h20 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acutus...
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
26 janv. 2022 13h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now...
BioSig to Present at the 27th Annual International AF Symposium
07 janv. 2022 10h20 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig to Present at the 24th Annual Virtual Needham Growth Conference
06 janv. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2
04 janv. 2022 08h30 HE
|
ARCA biopharma, Inc.
Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF)In a Phase 2B clinical trial, the prevalence of clinically important...
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales
21 déc. 2021 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Expands Its Clinical Footprint In Florida
16 déc. 2021 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...